The Antiretrovirals in Pregnancy Registry: A Fifteenth Anniversary Celebration

    loading  Checking for direct PDF access through Ovid

Abstract

Target Audience:

Obstetricians & Gynecologists, Family Physicians

Learning Objectives:

After completion of this article, the reader should be able to explain the value of a drug registry in determining safety risk management; summarize that the Antiretroviral (ARV) drugs in Pregnancy Registry (APR) is a very successful multinational, multicompany collaborative effort that has been in place for 15 years; and state that it has been an ideal public interest effort dealing with the devastating pandemic of human immunodeficiency viral disease.

Related Topics

    loading  Loading Related Articles